Barry Bockow

589 total citations
11 papers, 469 citations indexed

About

Barry Bockow is a scholar working on Rheumatology, Pharmacology and Immunology. According to data from OpenAlex, Barry Bockow has authored 11 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 4 papers in Pharmacology and 3 papers in Immunology. Recurrent topics in Barry Bockow's work include Inflammatory mediators and NSAID effects (4 papers), Osteoarthritis Treatment and Mechanisms (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). Barry Bockow is often cited by papers focused on Inflammatory mediators and NSAID effects (4 papers), Osteoarthritis Treatment and Mechanisms (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). Barry Bockow collaborates with scholars based in United States, Netherlands and Switzerland. Barry Bockow's co-authors include Roy Fleischmann, S. Roth, Ronald J. Rapoport, Frederick R. Dietz, Joel E. Rutstein, Peter G. Lacouture, Mart Mannik, Tamara Kaplan, Amy T. Ko and Sean Curtis and has published in prestigious journals such as The American Journal of Medicine, Annals of the Rheumatic Diseases and Knee Surgery Sports Traumatology Arthroscopy.

In The Last Decade

Barry Bockow

11 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry Bockow United States 9 184 173 134 118 107 11 469
G C Fenn United Kingdom 9 199 1.1× 53 0.3× 41 0.3× 20 0.2× 27 0.3× 14 437
G. Lynn Rasmussen United States 9 99 0.5× 54 0.3× 30 0.2× 15 0.1× 61 0.6× 15 322
Osman Aydın Türkiye 9 47 0.3× 51 0.3× 27 0.2× 20 0.2× 47 0.4× 35 312
Suzanne Meeves United States 13 43 0.2× 11 0.1× 168 1.3× 12 0.1× 85 0.8× 32 522
S. Nummi Finland 15 32 0.2× 35 0.2× 7 0.1× 154 1.3× 31 0.3× 27 503
Ta‐Liang Chen Taiwan 8 41 0.2× 15 0.1× 64 0.5× 16 0.1× 8 0.1× 9 405
Shou‐Hung Tang Taiwan 13 106 0.6× 14 0.1× 31 0.2× 32 0.3× 116 1.1× 41 523
Shaloo Pandhi Switzerland 8 67 0.4× 12 0.1× 72 0.5× 8 0.1× 58 0.5× 11 282
Hiroaki Abe Japan 10 50 0.3× 58 0.3× 88 0.7× 39 0.3× 5 0.0× 31 312

Countries citing papers authored by Barry Bockow

Since Specialization
Citations

This map shows the geographic impact of Barry Bockow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Bockow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Bockow more than expected).

Fields of papers citing papers by Barry Bockow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Bockow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Bockow. The network helps show where Barry Bockow may publish in the future.

Co-authorship network of co-authors of Barry Bockow

This figure shows the co-authorship network connecting the top 25 collaborators of Barry Bockow. A scholar is included among the top collaborators of Barry Bockow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Bockow. Barry Bockow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Bockow, Barry & Tamara Kaplan. (2013). Refractory immune thrombocytopenia successfully treated with high-dose vitamin D supplementation and hydroxychloroquine: two case reports. Journal of Medical Case Reports. 7(1). 91–91. 27 indexed citations
2.
Arden, Nigel, Thomas J. Schnitzer, C. Birbara, et al.. (2013). Intra‐articular hylastan versus steroid for knee osteoarthritis. Knee Surgery Sports Traumatology Arthroscopy. 22(7). 1684–1692. 38 indexed citations
3.
Spitzer, Andrew I., Barry Bockow, Victoria A. Brander, et al.. (2010). Hylan G-F 20 Improves Hip Osteoarthritis: A Prospective, Randomized Study. The Physician and Sportsmedicine. 38(2). 35–47. 36 indexed citations
4.
Curtis, Sean, et al.. (2005). Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489]. BMC Musculoskeletal Disorders. 6(1). 58–58. 38 indexed citations
5.
Kafka, Shelly, et al.. (2001). SAT0064 Treatment with etoricoxib (mk-0663), a cox-2 selective inhibitor, resulted in clinical improvement in knee osteoarthritis (oa) over 52 weeks. Annals of the Rheumatic Diseases. 60. A173–A173. 4 indexed citations
6.
Roth, S., Roy Fleischmann, Frederick R. Dietz, et al.. (2000). Around-the-Clock, Controlled-Release Oxycodone Therapy for Osteoarthritis-Related Pain. Archives of Internal Medicine. 160(6). 853–853. 238 indexed citations
7.
Appelrouth, Daniel J., Arthur D. Bankhurst, Joseph J. Biundo, et al.. (1987). Long-term treatment of rheumatoid arthritis comparing nabumetone with aspirin. The American Journal of Medicine. 83(4). 44–49. 15 indexed citations
8.
Pisko, Edward J., Barry Bockow, Francis X. Burch, et al.. (1987). Six-month multi-center study comparing nabumetone with naproxen in the treatment of osteoarthritis. The American Journal of Medicine. 83(4). 86–91. 19 indexed citations
9.
Vasey, Frank B., Bernard F. Germain, Luis R. Espinoza, et al.. (1987). Controlled evaluation of nabumetone in the treatment of active adult rheumatoid arthritis. The American Journal of Medicine. 83(4). 55–59. 14 indexed citations
10.
Bockow, Barry & Mart Mannik. (1981). Clearance and tissue uptake of immune complexes in complement-depleted and control mice.. PubMed. 42(4). 497–504. 39 indexed citations
11.
Bockow, Barry. (1975). Early child care in Sweden. Social Science & Medicine (1967). 9(10). 567–568. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026